Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Kiromic Biopharma, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +3 vs. Q1 2021
- Shares held
- 2.48M
- +2.12M (+593.6%) vs. Q1 2021
- Total value
- $11.9M
- +$8.57M (+256.6%) vs. Q1 2021
- New holders
- 7
- 5 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 5 | $6.13K |
| Q1 2023 | 7 | $78.2K |
| Q4 2022 | 12 | $145.5K |
| Q3 2022 | 16 | $90.3K |
| Q2 2022 | 17 | $200.0K |
| Q1 2022 | 20 | $1.73M |
| Q4 2021 | 21 | $3.82M |
| Q3 2021 | 23 | $7.49M |
| Q2 2021 | 16 | $11.9M |
| Q1 2021 | 13 | $3.34M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Kiromic Biopharma, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kepos Capital LP | 767,000 | $3.69M | 0.27% | +767,000 | New |
| Sabby Management, LLC | 500,508 | $2.41M | 0.52% | +500,508 | New |
| 1492 Capital Management LLC | 358,006 | $1.72M | 0.89% | +172,069+92.5% | Added |
| Altium Capital Management LP | 333,475 | $1.60M | 0.37% | +333,475 | New |
| Vanguard Group Inc | 119,304 | $574.0K | 0.00% | +108,890+1,045.6% | Added |
| Murchinson Ltd. | 100,000 | $481.0K | 0.18% | +100,000 | New |
| Intellectus Partners, LLC | 74,900 | $360.0K | 0.08% | +36,750+96.3% | Added |
| Warberg Asset Management LLC | 63,000 | $303.0K | 0.09% | +63,000 | New |
| FNY Investment Advisers, LLC | 60,000 | $288.0K | 0.12% | +60,000 | New |
| Redmond Asset Management, LLC | 45,336 | $218.0K | 0.06% | −76−0.2% | Reduced |
| Shay Capital LLC | 25,000 | $120.0K | 0.03% | +25,000 | New |
| Zeke Capital Advisors, LLC | 16,899 | $81.0K | 0.01% | −30,100−64.0% | Reduced |
| BlackRock Inc. | 9,627 | $46.0K | 0.00% | +4,510+88.1% | Added |
| Morgan Stanley | 3,200 | $15.0K | 0.00% | +1,800+128.6% | Added |
| Wells Fargo & Company | 8 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 33 | $0 | 0.00% | −2−5.7% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,725−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,749−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −50−100.0% | Sold out |